Health News Archive - May 29, 2009
New guidelines are now setting how much weight a women should gain during a pregnancy.
GLENWOOD, Ill., May 29 /PRNewswire-FirstCall/ -- Landauer, Inc. (NYSE: LDR) announced today that Douglas R. Gipson has been named Chief Nuclear Executive, effective May 15, 2009. Gipson will assume overall responsibility for Landauer's Global Nuclear Power Business.
SAN DIEGO, May 29 /PRNewswire-FirstCall/ -- Amylin Pharmaceuticals, Inc.
PITTSBURGH, May 29 /PRNewswire-FirstCall/ -- Mylan Inc. (Nasdaq: MYL) today announced that it has received tentative approval from the U.S.
NEW HAVEN, Conn., May 29 /PRNewswire-FirstCall/ -- VION PHARMACEUTICALS, INC.
COLLEGEVILLE, Pa., May 29 /PRNewswire-FirstCall/ -- Wyeth Pharmaceuticals, a division of Wyeth (NYSE: WYE), today announced preliminary data from two ongoing studies, one evaluating neratinib (HKI-272) in combination with trastuzumab (Herceptin(R), Roche) in HER-2 positive (ErbB-2 positive) breast cancer, and a separate study investigating neratinib safety and efficacy when given with paclitaxel (Taxol(R), Bristol-Myers Squibb) in patients with HER-2 dependent solid tumors.
- Largest Genomic Study Comparing Gene Expression in Female and Male Patients Presented at ASCO Annual Meeting - ORLANDO, Fla., May 29 /PRNewswire-FirstCall/ -- Genomic Health, Inc.
BrachyVision Acuros, Enabling Superior Dose Calculation with Unmatched Speed, Unveiled at ABS 2009 in Toronto, Canada, May 31-June 2 CHARLOTTESVILLE, Va., May 29 /PRNewswire-FirstCall/ -- Varian Medical Systems (NYSE: VAR) will be demonstrating its full range of brachytherapy cancer treatment equipment and software at the American Brachytherapy Society meeting in Toronto, Canada, from May 31 to June 2.
- Besivance Adds to Bausch & Lomb's Expanding Ocular Pharmaceuticals Portfolio and Offers New Therapeutic Option for a Wide Range of Ocular Bacterial Pathogens(1) - MADISON, N.J., May 29 /PRNewswire/ -- Bausch & Lomb, a world leader in eye health, today announced that the U.S.
Scientists have discovered a way to fight cancer using a new gene-scanning method that silences genes used by tumors to stay alive.